Gatinox 400 mg (Tablet)
Unit Price: ৳ 10.00 (2 x 10: ৳ 200.00)
Strip Price: ৳ 100.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Gatifloxacin |
| Company | Eskayef Pharmaceuticals Ltd. |
Indications
- Acute Bacterial Exacerbation of Chronic Bronchitis
- Acute Sinusitis
- Community-acquired Pneumonia
- Uncomplicated Skin and Skin Structure Infections
- Uncomplicated Urinary Tract Infections
- Complicated Urinary Tract Infections
- Pyelonephritis
- Uncomplicated Urethral and Cervical Gonorrhea
- Acute, Uncomplicated Rectal Infections in Women
Pharmacology
Acts by inhibiting DNA synthesis in susceptible organisms via inhibition of both DNA gyrase and topoisomerase IV
Dosage
- 400 mg 5 days for Acute Bacterial Exacerbation of Chronic Bronchitis
- 400 mg 10 days for Acute Sinusitis
- 400 mg 7-14 days for Community-acquired Pneumonia
- 400 mg 7-10 days for Uncomplicated Skin and Skin Structure Infections
Administration
Can be administered without regard to food
Contraindications
Patients with a history of hypersensitivity of Gatifloxacin, quinolone antimicrobial agents, or any other components of this product
Side Effects
- Nausea
- Vomiting
- Stomach pain
- Diarrhea
- Dizziness
- Headache
Pregnancy & Lactation
- Gatifloxacin should be used during pregnancy only if the potential benefit outweighs the potential risk to the fetus
- Caution should be exercised when gatifloxacin is administered to a nursing woman
Precautions & Warnings
Should be administered with caution in the presence of renal insufficiency
Use in Special Populations
- Creatinine Clearance 40 mL/min: 400 mg every day
- Creatinine Clearance < 40 mL/min: 400 mg 200 mg every day
- Hemodialysis: 400 mg 200 mg every day
- Continuous peritoneal dialysis: 400 mg 200 mg every day
- The safety and effectiveness of Gatinoxacin in pediatric populations (<18 years of age) have not been established
Overdose Effects
Exhibits a low potential for acute toxicity in animal studies
Therapeutic Class
4-Quinolone preparations